# MDLIVE

Published visit scope, benefit-dependent pricing and a messaging window make the offer assessable. The account-specific benefit and eligibility checks remain essential.

- **Canonical:** https://www.30plusskin.care/brands/mdlive
- **Site:** 30+/SKIN — Skincare, published as a spec sheet.
- **Issue:** ISSUE NO. 13 / REV. 2026.10
- **Standing terms:** INDEPENDENT · AFFILIATE-FUNDED · NOT MEDICAL ADVICE

---

## The operation

- **Category:** ONLINE DERMATOLOGY · PLAN-DEPENDENT VISITS
- **Model:** Photo-based dermatology assessment with pharmacy prescribing when appropriate.
- **Products assessed:** 1
- **Mean score:** 85/100
- **Mean disclosure score:** 85/100
- **Pricing:** See each offer and billing period in the product records
- **Brand site:** https://www.mdlive.com/
- **REVIEW SCOPE:** 1 OFFERING · NOT A CATALOGUE AUDIT
- **RESEARCH CHECKED:** 13 SEPTEMBER 2026
- **METHOD:** PUBLIC-SOURCE DESK REVIEW
- **SCORE SCOPE:** SEE EACH REVIEW'S SCORED CRITERIA

## Verdict

The dermatology offer provides concrete questions to compare with a cash consultation: what is covered, who assesses the concern and how long questions can be asked after the visit.

Our review covers the public dermatology terms. It does not establish the performance of the network or the care a particular patient would receive.

## What the reviewed offering tells us

### 01 — A copay is an individual result

An advertised low copay depends on the plan and service. Check dermatology benefits specifically, then price the proposed medicine and any later reassessment separately.

### 02 — A defined window needs a next step

Before starting a longer treatment, establish the route back to the clinician after included messaging ends. A convenient first assessment and continuity over several months are related but different purchasing questions.

## Credit where it is due

- Defines the one-condition visit and messaging scope.
- States eligibility exclusions and the separate cost of in-person care.

## Disclosure matrix

| Product | OFFICIAL SOURCE | PERSONAL OUTCOMES TESTED |
| --- | --- | --- |
| MDLIVE Online Dermatology | yes | no |

## Reviews

| No. | Product | Stance | Score | Price | Document |
| --- | --- | --- | --- | --- | --- |
| R-71 | Online Dermatology | CONDITIONAL | 85/100 | $0–$95 | /reviews/mdlive-dermatology-review |

## Sources

- [MDLIVE — dermatology pricing and FAQs](https://www.mdlive.com/dermatology) — Plan-dependent $0–$95 range, one condition per visit, clinician choice, 30-day messaging and eligibility exclusions. Checked 13 September 2026.

## Related records

- [R-71 MDLIVE Online Dermatology](/reviews/mdlive-dermatology-review)
- [R-62 SkyMD Online Dermatology](/reviews/skymd-online-dermatology-review)
- [L-18 Prescription skincare follow-up: what to establish before the first refill](/ledger/prescription-skincare-follow-up)
- [L-15 Online prescription skincare companies: compare the route to care](/ledger/online-prescription-skincare-companies)

---

## PROMOTIONAL SPOTLIGHT: Explore CoreAge Rx skincare

More options for your skin. A patient community to connect with along the way.

**Five skincare options to explore** — Browse CoreAge Rx's prescription skincare range for concerns including fine lines, dark spots, blemishes and more.

**Connect with other patients** — Explore the CoreAge Rx patient community for shared experiences, conversations and support beyond your daily routine.

[CHECK OUT COREAGE RX SKINCARE](https://try.coreagerx.com/skincare?utm_source=30plusskin.care&utm_medium=affiliate&utm_campaign=skincare_reviews&utm_content=reading_footer)

[EXPLORE THE PATIENT COMMUNITY](https://community.coreagerx.com/)

[Read our CoreAge Rx reviews](/reviews/coreage-rx-skincare-review)

Prescription options require a clinician's assessment. Compounded medications are not FDA-approved. Community discussions do not replace medical advice.

[Product range](https://help.coreagerx.com/medication/coreage-rx-prescription-skincare) · [Community information](https://www.coreagerx.com/contact-us/)

[About promotional placements](/disclosure)

---

## Elsewhere in the register

- [Review register](/reviews)
- [Active monographs](/actives)
- [Brand register](/brands)
- [Evidence register](/evidence)
- [The ledger](/ledger)
- [How we test](/how-we-test)
- [Agent guide](/llms.txt)
- [Sitemap](/sitemap.xml)

_SOURCE-BASED ASSESSMENTS. PUBLISHER PREFERENCES ARE IDENTIFIED SEPARATELY._